Heart safety study of verducatib in healthy adults
Treatments studied
This study tests how different doses of the drug verducatib affect the heart in healthy adults. Participation helps ensure the drug is safe before it's studied in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be generally healthy
- Be between 18 and 50 years old
- Have a BMI between 18.5 and 29.9
- Have no significant heart, liver, or electrolyte abnormalities
- Not be taking certain medications (details provided by the study team)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how two different tablet versions of a combination of vicadrostat and empagliflozin are absorbed by the body. It is for healthy volunteers to see which form works better.
This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
This study checks how safe the medicine vericiguat is for Japanese people with chronic heart failure when used in everyday care. It compares patients who receive vericiguat with patients who continue standard treatments without vericiguat.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.